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1. Introduction 
Maturation (meiosis) is the transformation, upon 
hormonal stimulation, of a diploid ovarian oocyte into 
a haploid and fertilizable egg (review [ 11). 
In amphibians, in vitro maturation of oocytes dis- 
sected out of the ovary can generally be induced by a 
short incubation of the oocytes with progesterone. In 
Xenopus laevis, the process of maturation extends 
over 6-10 h; it involves several different steps the 
most important of which, from a biological viewpoint, 
is the appearance of the maturation promoting factor 
(MPF) after 4-6 h hormonal treatment [2]. 
An essential step in the initiation of maturation is 
the dephosphorylation of certain classes of proteins. 
This phenomenon is believed to result from the fol- 
lowing sequence of events: an intracellular release of 
membrane-bound Ca2* would be instantaneously trig- 
gered by progesterone; Ca’+and calmodulin would 
activate a cyclic AMP (CAMP)-phosphodiesterase. A 
drop of CAMP content would follow; as a result, a 
cAMPdependent protein kinase activity would 
decrease with a subsequent dephosphorylation of pro- 
teins. 
Some of these steps are well substantiated by 
experimental data, whereas others are still hypotheti- 
cal: it has been established that progesterone treat- 
ment induces the release of Ca2+from the membrane 
within 30-90 s [3]; a calmodulin-like protein has been 
isolated from Xenopus oocytes [4]; moreover, Ca2+-- 
calmodulin injected into oocytes has been reported to 
induce their maturation [5], but it has not yet been 
proved that Ca’+and calmodulin activate in vivo an 
oocytic CAMP-phosphodiesterase. However, in [6] 
protein dephosphorylation is clearly indicated as an 
essential event for the initiation of maturation. Injec- 
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tion into the oocytes of either highly purified prepa- 
rations of the regulatory (R) subunit of the CAMP- 
dependent protein kinase or of the thermostable pro- 
tein kinase inhibitor (I) both induce maturation. How- 
ever, injection of the catalytic (C) subunit inhibits 
progesterone-induced maturation. The inhibition of a 
cAMPdependent kinase should result from a drop in 
CAMP content of the oocyte. However, the results 
obtained on the CAMP content in Xenopus laevis 
oocytes are discrepant: apparently, a drop in CAMP 
content occurs either at the very beginning (30 s) of 
progesterone treatment [7], or after 3 h [8], or even 
does not occur at all [9-l 11. 
A change in cAMPlevel may be induced by changes 
in activities of either adenylate cyclase or phospho- 
diesterase which, respectively, control the rate of 
CAMP synthesis and degradation. It has been shown 
[ 121 that adenylate cyclase is inhibited after a 1 h 
treatment with progesterone, but nothing is known 
about the behavior of the enzyme at earlier stages in 
the processof maturation.On the other hand, phospho- 
diesterase has been measured in vitro after a 1 h pro- 
gesterone treatment and its activity was not modified 
]131. 
Owing to the almost instantaneous release of mem- 
brane Ca2+ [3], and to the possible fast effect of pro- 
gesterone on CAMP content of the oocytes [7], we 
have investigated the in vivo behaviour of phospho- 
diesterase and adenylate cyclase during the first min- 
utes of progesterone treatment. 
For adenylate cyclase determinations, we have 
worked out experimental conditions allowing a suffi- 
cient protection of the neosynthesized labelled CAMP 
without impairing maturation as is the case with phos- 
phodiesterase inhibitors such as isobutylmethylxan- 
thine or theophyllin. 
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We report here that progesterone treatment does 
not modify the activity of phosphodiesterase at least 
during the first IO min; in contrast, adenylate cyclase 
activity is inhibited by progesterone, but only right at 
the beginning of the hormonal treatment. 
2. Material and methods 
Female Xenopus Zaevis were obtained from a dealer. 
Full-grown oocytes (stage VI, [ 141) were isolated by 
manual dissection with watchmaker’s forceps and 
maintained in modified Barth’s solution (MBS) [ 151 
without antibiotics. Germinal vesicle breakdown 
(GVBD) in oocytes treated with progesterone 
(10 pg/ml) was followed by observing the appearance 
of a white spot at the animal pole, and ascertained by 
dissection of the boiled oocytes. 
In enzymatic determinations, each point of the 
kinetic studies represents the mean of 5 determina- 
tions made on groups of 5 oocytes each (SEM indi- 
cated in the figures). The injection of 5 oocytcs takes 
at most 30 s. 
2 .I . Phosphodiesterase activity 
c L3H] AMP (0.3 ng = 10 000 cpm) 50 nl, were 
injected into each oocyte. At the indicated times, the 
oocytes were placed in ice-cold 1 M PCA, homogenized 
and centrifuged at 3000 X g for 10 min. The superna- 
tant was purified over an alumina column (1 g), as in 
[ 161 and then over a 2 ml Dowex AG 1 -X2 column as 
follows: after loading the Dowex column with the for- 
mate eluate from the alumina column, adenosine was 
eliminated with 10 ml 0.5 mM HCl. cAMP was sub- 
sequently recovered by eluting the column with 3 ml 
0.5 M HCl ([ 171; M. G., unpublished). After addition 
of 6 ml Aquasol- NEN, the eluates were counted in a 
liquid scintillator.The recovery from the column puri- 
fication was measured by addition of a known amount 
ofc[3H]AMPtoaPCAextract ofoocytes,andrepro- 
ducibly found to be -85%. 
2.2. Adenyhzte cyclase activity 
Each oocyte was injected with 50 nlO.1 M MES 
(pH 6 -5) containing 700 000 cpm of fc~-~*P] ATP. 
c [“‘PI AMP was extracted, purified and measured as 
above. 
3. Results and discussion 
3.1 . Deter?n~nation 0~cA~P~~~osp~odiesterase 
activity 
3.2 .l . Effect of progesterone 
After the injection of tracer c 13H]AMP, the oocytes 
were immediately transferred into either plain or pro- 
gesterone~ontaining MBS. The fate of ci3HjAMP was 
followed during the first 10 min after its injection 
(fig.l). 
Fig.1 shows that the activity of phosphodiesterase 
measured in vivo in the oocytes is linear during at least 
10 min. During this period, progesterone does not 
modify the activity of the enzyme at all. 
It should be pointed out that the injected tracer 
c [3H]AMP (0.3 ng) only dilutes the endogenous pool 
(1 .O ng) of the oocyte slightly. We thus consider that 
our phosphodiesterase determinations reflect better 
the true in vivo situation than estimations made in the 
presence of a huge excess of injected CAMP [8], which 
might artificially enhance the activity of the enzyme. 
3.2. Determination of adenylate cyclase activity 
3 2 .I. Conditions for in vivo determination 
We have designed conditions to protect the CAMP 
neosynthesized from [cY-~~P]ATP during in vivo aden- 
ylate cyclase determinations. Injection of a large 
excess of unlabelled CAMP into the oocytes allowed a 
10 
Time1 minutes ) 
Fig.1. Determination of phosphodiesterase activity in oocytes 
injected with +lO 000 cpm each of c13H]AMP (0.3 ng) and 
immediately placed in MBS (0) or MBS containing 10 rg/ml 
progesterone (0). At different times after the injection, the 
remaining cj3H]AMP was extracted and purified as in sec- 
tion 2. Each determ~ation was performed on 5 batches of 
5 oocytes. 
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Fig.2. Effect of an excess of injected cold CAMP on the in vivo 
hydrolysis of tracer c[~H]AMP. Each oocyte received)50 nl 
0.1 M MES buffer (pH 6.5) with either +lO 000 cpm (0.3 ng) 
of c13H]AMP alone (0) or the same containing in addition 
50 ng (0) or 100 ng (n) of unlabeiled CAMP. Other oocytes 
(A) were preincubated for 3 h with 1 .O mM IBMX before the 
injection of c[ 3H]AMP. At the indicated times after the injec- 
tion, the remaining c[‘H]AMP was extracted and purified as 
in section 2. Each determination was performed on 5 batches 
of 5 oocytes. 
substantial protection of the tracer c[~H]AMP (fig.2). 
CAMP at 50 or 100 ngloocyte (i.e., 50- or lOO-times 
their endogenous content) respectively, inhibit by 
67% and 77% the disappearance of c [3H]AMP during 
the 10 min following injection. 
We have also studied the protective effect of iso- 
butyl-methyl-xan~ine (IBMX) reported [ 121 to 
totally inhibit the in vitro activity of phosphodiester- 
ase in Xenopus Iaevis oocytes. We show here that this 
methylxanthine slows down the activity of phospho- 
diesterase by only 50% in 10 min when measured in 
vivo (fig.2). 
It can be seen that preincubation in IBMX as well 
as injection of 50 ng CAMP ensures a good protection 
of a tracer amount of c[~H]AMP injected into the 
oocytes. However, increasing the intracellular content 
of CAMP seems to be preferable: as illustrated in Iig.3, 
IBMX totally impairs progesterone-induced matura-. 
tion, as shown in ] 181, whereas an excess of CAMP 
only slightly delays GVBD. 
3.2.2. Effect of progesterone 
The above results led us to carry out the in vivo 
assay of adenylate cyclase activity by injecting into 
each oocyte 50 ng unlabeIled CAMP together with 
[(u-32P]ATP. Under these conditions, we first observed 
(not shown) that the amount of c [32P] AMP recovered 
remains linear for only 4 min after the injection of 
10 
Time (hours) 
Fig.3. Effect of injected CAMP on the rate of maturation 
(GVBD). Oocytes (30) were injected with 50 nl each of 0.1 M 
MES buffer (pH 6.5) either alone (0) or containing 50 ng 
CAMP (0) or 100 ng CAMP (n). Immed~tely after the injec- 
tion, the oocytes were placed in MBS containing 10 ~g pro- 
gesterone/ml. Some oocytes (A) were preincubated for 3 h in 
1 mM IBMX in MBS, then transferred into a progesterone 
solution. The percentage of GVBD was scored at different 
times of progesterone treatment. 
[cY-~*P]ATP. At later times, the increase in the c[~*P]- 
AMP recovered was no longer linear with time. The 
observed plateau must result from many conflicting 
enzymatic activities (ATPase, phosphodiesterases). 
Fig.4 illustrates the behaviour of adenylate cyclase 
Fig.4. Determination of adenylate cyclase activity in oocytes 
injected with 50 nl each of 0.1 M MES buffer (pH 6.5) con- 
taining 50 ng unlabelled CAMP and *700 000 cpm of [o?P]- 
ATP. Immediately after the injection, the oocytes were placed 
in MBS (a) or MBS containing 10 pg progesterone/ml (0). 
Other oocytes (A) were preincubated for 3 h in MBS contain- 
ing 1 mM IBMX, then injected with 50 nl 0.1 M MES buffer 
(pH 6.5) containing 2700 000 cpm of [&*P]ATP and main- 
tained in the I3MX solution for 1 h (inset). At the indicated 
times after the injection of [c~-“*P]ATP, CAMP was extracted 
and purified as in section 2. Adenylate cyclase activity was 
expressed as the ratio of 32P counts found in CAMP over the 
31P counts in the injected ATP X 10’. Each determination 
was performed on 5 batches of 5 oocytes. 
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in control oocytes and following hormonal treatment. 
It shows that progesterone inhibits the activity of 
adenylate cyclase: only 40% and 60% of the c[‘*P]- 
AMP found in the controls were recovered after 2 and 
4 min progesterone treatment, respectively. This inhi- 
bition is transient, since after 15 min the amount of 
c[~*P]AMP~~ the same in progesterone-treated and in 
control oocytes. 
The inset shows that even after a 3 h pretreatment 
with IBMX, the activity of adenylate cyclase ceases to 
be linear already after 6 min; this result was to be 
expected since we have shown (fig.2) that the oocyte’s 
phosphodiesterase is only partially inhibited by IBMX 
in vivo. Therefore, even in the presence of IBMX, the 
only reliable data on adenylate cyclase activity in 
oocytes are those recorded in the first S min after 
injection of [~Y-~*P]ATP; this makes questionable the 
physiological meaning of the cyclase activities mea- 
sured 1 h after the injection of the radioactive sub- 
strate [12]. 
The early and transient decrease in adenylate cyclase 
activity reported here is consistent with [7] where 
CAMP content of the oocyte dropped by 40% during 
the first 60 s progesterone treatment, thenreturned to 
its basal level after 10 min. 
It is likely that the increase in Ca*+ temporarily 
released from the cortex as a primary response to pro- 
gesterone induces, an inhibition of adenylate cyclase 
rather than an activation of CAMP phosphodiesterase, 
perhaps via a Ca*+ -calmodulin complex. Indeed, a 
biphasic response of adenylate cyclase to changes in 
[Ca*‘] has been described in brain [ 191 where the 
activity of the enzyme is slowed down in the presence 
of an excess of Ca*+. 
Our results substantiate the hypothesis that a drop 
of CAMP is a prerequisite for the release of the meiotic 
block. It has been shown that cholera toxin, which 
irreversibly stimulates adenylate cyclase in animal cells 
[20], is an inhibitor of progesterone-induced matura- 
tion [21]. Since we have shown [22] that an injection 
of GTP in the oocytes also inhibits progesterone- 
induced maturation, it was expected to find an activa- 
tion of adenylate cyclase in the injected oocytes, by 
analogy with the action of cholera toxin. But it seems 
from preliminary results obtained in our laboratory 
that GTP does not activate an adenylate cyclase in the 
oocytes and that the inhibition of progesterone-induced 
maturation is to be ascribed to a rather unexpected 
inhibition of CAMP phosphodiesterase, which is remi- 
niscent of the effects of IBMX [ 181. 
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